| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |